R-(-)-Apomorphine
R-(-)-Apomorphine Basic information
- Product Name:
- R-(-)-Apomorphine
- Synonyms:
-
- (r)-5,6,6a,7-tetrahydro-6-methyl-4h-dibenzo[de,g]quinoline-10,11-diol
- Apomorphine hydrochloride R-(-)-
- (6Ar)-5,6,6A,7-tetrahydro-6-methyl-4H-dibenzo(de,G)chinolin-10,11-diol hydrochlorid
- 6a-beta-aporphine-10,11-diol
- APOMORPHINE HYDROCHLORIDE, HEMIHYDRATE
- 4H-Dibenzode,gquinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, hydrate (2:1), (6aR)-
- APOMORPHINEHCLHEMIHYDRATE
- APOMORPHINEHYDROCHLORIDE,HEMIHYDRATE,USP
- CAS:
- 41372-20-7
- MF:
- C17H20ClNO3
- MW:
- 321.8
- EINECS:
- 627-402-4
- Product Categories:
-
- Inhibitors
- APOKYN
- Chiral Reagents
- Heterocycles
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Erectile Dysfunction
- Agonists
- Dopaminergics
- Neurotransmitters
- Dopamine receptor
- Mol File:
- 41372-20-7.mol
R-(-)-Apomorphine Chemical Properties
- Melting point:
- 285-287 °C(lit.)
- alpha
- -48 º (c=1, H2O)
- storage temp.
- Refrigerator
- solubility
- H2O: ~10 mg/mL, clear, yellow-green
- form
- Solid
- color
- white to gray
- PH
- pH(10g/l, 25℃) : 4.0～5.0
- Merck
- 13,751
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in distilled water may be stored at -20°C for up to 1 week.
- CAS DataBase Reference
- 41372-20-7(CAS DataBase Reference)
MSDS
- Language:English Provider:SigmaAldrich
R-(-)-Apomorphine Usage And Synthesis
Description
Apomorphine (41372-20-7) is an archetypal dopamine pan-receptor agonist. Displays anti-Parkinsons activity in vivo.1 Protects against MPTP-induced neurotoxicity in a mouse mode1,2 In clinical use for Parkinson’s disease.4,5
Chemical Properties
Off-White Solid
Uses
emetic, antiparkinsonian, erextile dysfunction therapy
Uses
R-(?)-Apomorphine hydrochloride hemihydrate is a nonselective dopamine agonist with anti-Parkinsonian and neuroprotective effects in vivo.
Uses
Dopamine (D1 and D2) receptor agonist. Emetic. Antiparkinsonian.
brand name
Apokyn (Vernalis).
Purification Methods
Crystallise the salt from H2O (hemihydrate) and from EtOH. Crystals turn green on exposure to light. (see previous entry). NARCOTIC.
References
1) Merck Index 14:746 2) Millan et al. (2002), Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes; J. Pharmacol. Exp. Therap., 303 791 3) Grunblatt et al. (1999), Apomorphine protects against MPTP-induced neurotoxicity in mice.; Mov. Discord, 14 612 4) Auffret et al. (2017), Apomorphine pump in advanced Parkinson’s disease: Effects on motor and nonmotor symptoms with brain metabolism correlations; J. Neurol. Sci, 372 279 5) Jenner and Katzenschlager (2016), Apomorphine – pharmacological properties and clinical trials in Parkinson’s disease; Parkinsonism. Related. Disord., 33 Suppl. 1:S13
R-(-)-Apomorphine Preparation Products And Raw materials
Raw materials
R-(-)-ApomorphineSupplier
- Tel
- 1-(800)-881-8210
- inquiries@lgmpharma.com
- Tel
- 021-021-021-67601398-809-809-809 15221380277
- marketing_china@spectrumchemical.com
- Tel
- 021-33632979
- info@tsbiochem.com
- Tel
- 021-61415566 800-8193336
- orderCN@merckgroup.com
- Tel
- 857-239-0968
- service1@targetmol.com